Περιγραφή
Διάλυμα νερού-αλατιού του συμπλόκου πρωτεΐνης-πεπτιδίου 30 ml. Βιορυθμιστής ωοθηκών σε γυναίκες.
Βιορυθμιστής ωοθηκών σε γυναίκες.
Σύνθεση: 1 ml αποστειρωμένου διαλύματος περιέχει. 0,1 ± 0,01 mg CaCl2 και 10-10-10 -11 mg του συμπλόκου πρωτεΐνης-πεπτιδίου.
Αντενδείξεις: δεν βρέθηκαν. Υπερδοσολογία: εξαιρείται. Εθιστικό εφέ: απουσιάζει.
Συνθήκες αποθήκευσης: σε καθαρό, στεγνό, προστατευμένο από τον ήλιο σε θερμοκρασία +5 έως +25 ° C και σχετική υγρασία όχι μεγαλύτερη από 75%.
Water-salt solution of the protein-peptide complex. 30 ml. Bioregulator of ovarian tissue in women.
Bioregulator of ovarian tissue in women.
Composition: 1 ml of sterile solution contains; 0.1 ± 0.01 mg CaCl 2 and 10 -10 -10 -11 mg of the protein-peptide complex.
Recommendations for use: to improve ovarian function in women, stabilize hormonal status, and increase the likelihood of conception.
Method of application: 20-30 minutes before a meal, drip 10-15 drops of the solution under the tongue, drink a little water. Take 3-5 times a day. The course of admission is 2-3 months. Viorgon 13 is combined with the intake of other drugs, including medicinal ones. Especially effective is its combination with taking Viorgon 1 and Viorgon 12. Attention! Do not mix two or more drugs of this series in one volume and take them as a general solution at the same time!
Contraindications: not found. Overdose: excluded. Addictive effect: absent.
Storage conditions: in a clean, dry, protected from the sun place at a temperature of +5 to +25 ° C and a relative humidity of no more than 75%.
Expiration date: 18 months from the date of manufacture.
Release form: a 30 ml bottle (≈600 drops).
TU 10.89.19-001-90670862-2019.
Manufacturer / Organization authorized to accept claims: IPB LLC, Moscow, 119334, Leninsky prospect, 45-2, Tel: +7 (495) 650-18-10
Documents
Declaration
Size: 293.6 kb
